On Chemball
My Chemball
+86-571-8627 3270
WUHAN BJM PHARMACEUTIACLS CO.,LTD
WUHAN BJM PHARMACEUTIACLS CO.,LTD
11 YRS
Hubei, China
Main Products:
N-Methyl-1,2-Benzenediamine Dihydrochloride / Pirfenidone / Letrozole
Hubei, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
ABOUT US
Wuhan Benjamin Pharmaceutical Co., Ltd., founded in 2013, is located in Wuhan, Hubei Province, the thoroughfare of nine provinces, with convenient transportation and superior location.
The company has two joint-venture factories in Dezhou, Shandong and Xianning, Hubei, covering a total area of 48000 square meters and a construction area of 26000 square meters. It mainly produces a series of fine chemicals such as pharmaceutical intermediates and cosmetic additives, and has complete testing equipment and independent R & D capacity.
In 2013, Wuhan Benjamin Pharmaceutical Co., Ltd. (formerly Wuhan Benjamin pharmaceutical chemical raw materials Co., Ltd.) was established to obtain the import and export right, mainly responsible for the domestic and foreign sales of factory products. At the same time, we established an R & D laboratory in Wuhan, Hubei Province, which can undertake the customized synthesis business of various APIs and intermediates.
In 2016, he successfully took shares in Hubei Jiayu beiteao Technology Co., Ltd. and obtained the registered trademark bjm.
It was renamed Wuhan Benjamin Pharmaceutical Co., Ltd. in August 2018 and was listed on the new fourth edition of Wuhan capital building in October.
By may 2020, the company has applied for 4 product invention patents and 4 utility model patents.
On June 17, 2020, Wuhan Benjamin Pharmaceutical Co., Ltd. signed an agreement with East Lake High Tech Group, and the company's R & D building was officially confirmed to be located in Optics Valley NANDA Health Industrial Park!
Our main business scope is the R & D, production and sales of erdosten intermediates, relying on Lilin, ambuterol, pirfenidone, letrozole, sitagliptin phosphate, dapagliflozin and related intermediates.
Basic Information
Tax ID
91420100066847001N
Country/Region
Hubei, China
Year Established
2013
Registered Capital
CNY 5 Million
Business Type
CDMO
Total Employees
Less than 50 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Mainly produces pharmaceutical intermediates, cosmetic additives, etc
PLANT LOCATION
COMPANY ALBUM
